| Procalcitonin increase in early identification of critically ill patients at high risk of mortality JU Jensen, L Heslet, TH Jensen, K Espersen, P Steffensen, M Tvede Critical care medicine 34 (10), 2596-2602, 2006 | 563 | 2006 |
| Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis P Schuetz, Y Wirz, R Sager, M Christ-Crain, D Stolz, M Tamm, L Bouadma, ... The Lancet infectious diseases 18 (1), 95-107, 2018 | 485 | 2018 |
| Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial JU Jensen, L Hein, B Lundgren, MH Bestle, TT Mohr, MH Andersen, ... Critical care medicine 39 (9), 2048-2058, 2011 | 474 | 2011 |
| A neutralizing monoclonal antibody for hospitalized patients with Covid-19 Activ-3/Tico Ly-CoV555 Study Group New England Journal of Medicine 384 (10), 905-914, 2021 | 329 | 2021 |
| Biomarkers as point‐of‐care tests to guide prescription of antibiotics in patients with acute respiratory infections in primary care R Aabenhus, JUS Jensen, KJ Jørgensen, A Hróbjartsson, L Bjerrum Cochrane Database of Systematic Reviews, 2014 | 321 | 2014 |
| Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use P Schuetz, A Beishuizen, M Broyles, R Ferrer, G Gavazzi, EH Gluck, ... Clinical Chemistry and Laboratory Medicine (CCLM) 57 (9), 1308-1318, 2019 | 262 | 2019 |
| Acute COVID-19 and the incidence of ischemic stroke and acute myocardial infarction D Modin, B Claggett, C Sindet-Pedersen, MCH Lassen, KG Skaarup, ... Circulation 142 (21), 2080-2082, 2020 | 228 | 2020 |
| Sepsis: frontiers in diagnosis, resuscitation and antibiotic therapy A Perner, AC Gordon, D De Backer, G Dimopoulos, JA Russell, J Lipman, ... Intensive care medicine 42, 1958-1969, 2016 | 197 | 2016 |
| Acute exacerbations of chronic obstructive pulmonary disease: in search of diagnostic biomarkers and treatable traits AG Mathioudakis, W Janssens, P Sivapalan, A Singanayagam, ... Thorax 75 (6), 520-527, 2020 | 142 | 2020 |
| Eosinophil-guided corticosteroid therapy in patients admitted to hospital with COPD exacerbation (CORTICO-COP): a multicentre, randomised, controlled, open-label, non … P Sivapalan, TS Lapperre, J Janner, RR Laub, M Moberg, CS Bech, ... The Lancet Respiratory Medicine 7 (8), 699-709, 2019 | 137 | 2019 |
| Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised … WH Self, U Sandkovsky, CS Reilly, DM Vock, RL Gottlieb, M Mack, ... The Lancet Infectious Diseases 22 (5), 622-635, 2022 | 124 | 2022 |
| Mortality in enterococcal bloodstream infections increases with inappropriate antimicrobial therapy M Suppli, R Aabenhus, ZB Harboe, LP Andersen, M Tvede, JUS Jensen Clinical microbiology and infection 17 (7), 1078-1083, 2011 | 123 | 2011 |
| Pseudomonas aeruginosa and risk of death and exacerbations in patients with chronic obstructive pulmonary disease: an observational cohort study of 22 053 patients J Eklöf, R Sørensen, TS Ingebrigtsen, P Sivapalan, I Achir, JB Boel, ... Clinical Microbiology and Infection 26 (2), 227-234, 2020 | 105 | 2020 |
| Profound endothelial damage predicts impending organ failure and death in sepsis ME Johansen, PI Johansson, SR Ostrowski, MH Bestle, L Hein, ... Seminars in thrombosis and hemostasis 41 (01), 016-025, 2015 | 105 | 2015 |
| Procalcitonin-guided antibiotic treatment in patients with positive blood cultures: a patient-level meta-analysis of randomized trials MA Meier, A Branche, OL Neeser, Y Wirz, S Haubitz, L Bouadma, M Wolff, ... Clinical Infectious Diseases 69 (3), 388-396, 2019 | 104 | 2019 |
| Echocardiographic abnormalities and predictors of mortality in hospitalized COVID‐19 patients: the ECHOVID‐19 study MCH Lassen, KG Skaarup, JN Lind, AS Alhakak, M Sengeløv, AB Nielsen, ... ESC heart failure 7 (6), 4189-4197, 2020 | 102 | 2020 |
| Kidney failure related to broad-spectrum antibiotics in critically ill patients: secondary end point results from a 1200 patient randomised trial JUS Jensen, L Hein, B Lundgren, MH Bestle, T Mohr, MH Andersen, ... BMJ open 2 (2), e000635, 2012 | 102 | 2012 |
| Characteristics, interventions, and longer term outcomes of COVID‐19 ICU patients in Denmark—a nationwide, observational study N Haase, R Plovsing, S Christensen, LM Poulsen, AC Brøchner, ... Acta Anaesthesiologica Scandinavica 65 (1), 68-75, 2021 | 95 | 2021 |
| Point-of-care procalcitonin test to reduce antibiotic exposure in patients hospitalized with acute exacerbation of COPD C Corti, M Fally, A Fabricius-Bjerre, K Mortensen, BN Jensen, ... International Journal of Chronic Obstructive Pulmonary Disease, 1381-1389, 2016 | 81 | 2016 |
| Procalcitonin-guided antibiotic therapy algorithms for different types of acute respiratory infections based on previous trials P Schuetz, R Bolliger, M Merker, M Christ-Crain, D Stolz, M Tamm, ... Expert review of anti-infective therapy 16 (7), 555-564, 2018 | 67 | 2018 |
